E
Estrella Immunopharma, Inc. (ESLA)
NCM – Real vaqt narxi. Valyuta: USD
0.98
+0.03 (3.45%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.96
-0.03 (-2.55%)
Bozordan keyin: Jun 26, 2026, 7:42 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.98
+0.03 (3.45%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.96
-0.03 (-2.55%)
Bozordan keyin: Jun 26, 2026, 7:42 PM EDT
Daromad taqsimoti ma'lumotlari hali hisoblanmagan.
No Data
Ushbu aksiya uchun yangiliklar yo'q.
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 0.24 | 6.05 | 2.0 | |
| Tezkor likvidlik nisbati | 0.24 | 5.63 | 2.0 | |
| Qarz/Kapital nisbati | N/A | 0.30 | 1.0 | |
| Qarz/Aktivlar nisbati | 0.00 | 1.04 | 10 | |
| Foiz to‘lov qoplami | N/A | -16.91 | 1.0 | |
| O‘rtacha ball | 3.2 | |||
| KO‘RSATKICH | 2021 | 2022 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | N/A | N/A | N/A | N/A | N/A |
| Yalpi foyda | N/A | N/A | N/A | N/A | N/A |
| Operatsion daromad | -249K | -2M | -9M | -13M | -13M |
| Sof foyda | -248K | -996K | -9M | -13M | -13M |
| EBITDA | -249K | -2M | -9M | -13M | -13M |
| NOMI | KOEFF. | SANOAT | 5 YIL | BALL |
|---|---|---|---|---|
| Yalpi marja % | N/A | -11.73 | 1.0 | |
| Operatsion marja % | N/A | -24.60 | 1.0 | |
| Sof marja % | N/A | -172.20 | 1.0 | |
| EBITDA marja % | N/A | -201.27 | 1.0 | |
| Pul oqimi marja % | N/A | -156.39 | 1.0 | |
| O‘rtacha ball | 1.0 | |||
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | N/A | -17.31 | 1.0 |
| Keyingi chorak | N/A | 36.84 | 5.5 |
| Joriy yil | N/A | N/A | 1.0 |
| Keyingi yil | N/A | N/A | 1.0 |
| O‘rtacha ball | 2.1 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 999 | -273.79 | 26.32 | -3673.73 | 5.5 |
| Yil/Yil | 999 | -8.91 | -16.66 | -1337.39 | 3.3 |
| 3 yil o‘rtacha | 999 | -379.49 | N/A | -128.58 | 3.3 |
| 5 yil o‘rtacha | N/A | N/A | N/A | N/A | 1.0 |
| O‘rtacha ball | 3.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |
Naqd pul zahiralari $1.9M kelgusi qarz to'lovlarini $0.0 zo'rg'a qoplaydi
Jami joriy majburiyatlar $8.9M jami joriy aktivlardan $2.2M oshib ketdi, likvidlik muammolarini ko'rsatadi
Qarz/kapital nisbati (0.0) tarmoq o'rtachasiga yaqin bo'lib, muvozanatli leverajni aks ettiradi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
Salbiy erkin pul oqimi -$6.7M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi